In obese diabetic ob/ob mice, COS supplementation improved BW gain, dyslipidemia, and hyperglycemia, as well as regulated a variety of adipokine expression, shown by an increase in adiponectin and a decrease in RBP4, resistin, TNF-α, and IL-6 [81]. Here, ADIPOQ is linked to Hyperglycemia.